EP-1048: Phase I trial of a novel metalloporphyrin radiosensitiser (MTL005) in head and neck cancer. (April 2016) - Schipani, S.; Foran, B.; Guerrero Urbano, T.; Jürgens, H.; Beattie, C.; Caldwell, J.